10 тысяч подписчиков
474 видео
ESMO Sarcoma and Rare Cancers 2024: Robin L. Jones on why you should attend the Congress
ASCO 2023 Highlights on adjuvant osimertinib in resected EGFR mutated NSCLC: The ADAURA trial
Why young oncologists should attend ESMO Asia 2024 - Prof. Lim
ESMO Immuno-Oncology 2024 Congress Experts in the field invite you to share your research.
Claudia Cardone & Andreas Koulouris on how the ESMO Academy helps prepare for the ESMO Examination
Why you should submit your abstract for MAP 2024
#ESMOGynae24
ESMO Immuno-Oncology 2024: Congress Experts in the field invite you to share your research.
MAP 2024: shaping the future of precision oncology
ESMO Immuno-Oncology 2024: Experts in different tumour types explain the importance of this congress
ESMO Asia Congress 2024: multidisciplinary oncology in the Asian region
ESMO/ASCO Global Curriculum in Medical Oncology: Insights on the 2023 Edition
ESMO Immuno-Oncology 2024 Congress M. Maio, A. Marabelle and I. Svane invite you to attend
Why you should attend ESMO Asia 2024 - Prof. Cervantes
ESMO Breast Cancer 2025: Invitation from Scientific Committee Co-Chairs
ESMO Virtual Mentorship Programme
World renowned experts on why you should attend MAP 2024
Recommendations for the use of NGS in patients with metastatic cancer
ESMO Recommendations on clinical reporting of genomics test results for solid cancers
ESMO Women for Oncology Forum 2023: 10 years of ESMO W4O advocating for gender equity
MAP 2024: why you should attend this global congress in precision oncology
ESMO 2024: Join your international community in Barcelona, or Online
Precision Medicine in Prostate Cancer
Unlock your future: Why Young Oncologists should attend MAP 2024
ESMO Gynaecological Cancers Congress 2024 Members of the Scientific Committee invite you to register
ESMO Sarcoma and Rare Cancers 2024: What you can expect by attending
ESMO 2020 Expert Video Report on rare sarcomas histotypes
ESMO Sarcoma and Rare Cancers 2024: Claudia Valverde on why you should attend the Congress
#ESMO22
#ESMO21
A Global Policy Approach to Freedom from Cancer Pain
#ESMO23
Highlights on amivantamab after progression on osimertinib in EGFR-mutated NSCLC: MARIPOSA-2
ESMO 2020 Expert Video Report on precision medicine in prostate cancer
How to manage chemotherapy induced nausea and vomiting
Mechanisms of TKI resistance
Interview with Andrés Cervantes, elected ESMO President for 2022-2023
How To treat rectal cancer patients with adjuvant systemic therapy?
ESMO Targeted Anticancer Therapies Congress 2024: Global Experts On Why You Should Secure Your Seat
How to manage toxicities from Immune Checkpoint Inhibitors?
ESMO 2020 Highlights on 1st line lorlatinib for ALK+ NSCLC: The CROWN Study
Health economics in cancer
ESMO 2020 Expert Video Report on CDK4 6i in the adjuvant treatment of breast cancer
Discrepancies in Cancer Pain Treatment Across the Globe
ESMO Sarcoma and Rare Cancers 2024: The Scientific Committee on why you should attend
Adjuvant treatment for colon cancer: How to treat a stage III colon cancer?
How to protect yourself from coronavirus? The pivotal role of cancer nurses
ESMO Summit Latin America 2024: Invitation from the ESMO President
#ESMO24
